Mechanism of action of gut microbiota in chronic pancreatitis fibrosis and related treatment strategies
- VernacularTitle:肠道微生物在慢性胰腺炎胰腺纤维化中的作用机制及相关治疗策略
- Author:
Yunjun YAN
1
;
Liang SHENG
1
;
Qi WANG
1
;
Shun PENG
1
;
Jia LI
1
;
Lei ZHANG
1
Author Information
- Publication Type:Review
- Keywords: Gastrointestinal Microbiome; Pancreatitis， Chronic; Fibrosi; Therapeutics
- From: Journal of Clinical Hepatology 2026;42(2):484-489
- CountryChina
- Language:Chinese
- Abstract: Chronic pancreatitis （CP） is a common disease in clinical practice characterized by progressive inflammatory fibrosis of the pancreas. Gut microbiota， known as the “second genome” of humans， bidirectionally modulates the progression of fibrosis in CP via the gut-pancreas axis. This article systematically elaborates on the characteristics of gut microbiota during the progression of CP and its molecular mechanism in mediating pancreatic fibrosis through bacterial translocation， metabolites， immune regulatory networks， and microbe-pancreatic stellate cell interactions， with a focus on the pivotal role of short-chain fatty acids and inflammatory cytokine networks in pancreatic stellate cell activation and extracellular matrix deposition. In addition， this article explores the potential value of gut microbiota-targeted interventions in the prevention and treatment of CP fibrosis， such as probiotics， prebiotics， and fecal microbiota transplantation， and discusses the translational potential of using multi-omics technologies to identify diagnostic biomarkers and novel therapeutic targets for CP， in order to provide new ideas for the precise diagnosis and treatment of CP.
